Seilern Investment Management Ltd Cuts Stock Position in Veeva Systems Inc. $VEEV

Seilern Investment Management Ltd trimmed its holdings in shares of Veeva Systems Inc. (NYSE:VEEV) by 12.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 294,189 shares of the technology company’s stock after selling 41,860 shares during the period. Veeva Systems comprises 6.4% of Seilern Investment Management Ltd’s holdings, making the stock its 6th largest position. Seilern Investment Management Ltd’s holdings in Veeva Systems were worth $87,642,000 as of its most recent SEC filing.

Other hedge funds also recently modified their holdings of the company. Vanguard Group Inc. boosted its position in Veeva Systems by 1.4% during the second quarter. Vanguard Group Inc. now owns 14,971,425 shares of the technology company’s stock valued at $4,311,471,000 after purchasing an additional 210,859 shares during the last quarter. Alliancebernstein L.P. increased its position in shares of Veeva Systems by 3.7% during the 2nd quarter. Alliancebernstein L.P. now owns 5,705,648 shares of the technology company’s stock worth $1,643,113,000 after purchasing an additional 205,997 shares during the last quarter. JPMorgan Chase & Co. raised its stake in shares of Veeva Systems by 2.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 3,316,274 shares of the technology company’s stock worth $955,030,000 after purchasing an additional 85,516 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Veeva Systems by 3.8% in the 2nd quarter. Geode Capital Management LLC now owns 3,092,539 shares of the technology company’s stock valued at $888,108,000 after buying an additional 114,003 shares during the last quarter. Finally, AQR Capital Management LLC boosted its holdings in shares of Veeva Systems by 111.7% in the 2nd quarter. AQR Capital Management LLC now owns 1,838,046 shares of the technology company’s stock valued at $526,508,000 after buying an additional 969,905 shares during the last quarter. Institutional investors own 88.20% of the company’s stock.

Insider Activity at Veeva Systems

In other Veeva Systems news, insider Thomas D. Schwenger sold 3,350 shares of the company’s stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $300.04, for a total value of $1,005,134.00. Following the transaction, the insider directly owned 23,773 shares of the company’s stock, valued at $7,132,850.92. This represents a 12.35% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, insider Eleni Nitsa Zuppas sold 6,000 shares of Veeva Systems stock in a transaction on Tuesday, October 7th. The stock was sold at an average price of $306.62, for a total value of $1,839,720.00. Following the sale, the insider directly owned 25,325 shares of the company’s stock, valued at $7,765,151.50. This represents a 19.15% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 24,665 shares of company stock worth $7,438,000 in the last ninety days. 10.30% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

VEEV has been the topic of a number of recent analyst reports. Robert W. Baird boosted their target price on shares of Veeva Systems from $314.00 to $319.00 and gave the stock an “outperform” rating in a report on Friday, November 21st. Morgan Stanley lifted their price objective on shares of Veeva Systems from $210.00 to $222.00 and gave the company an “underweight” rating in a research report on Thursday, August 28th. JPMorgan Chase & Co. upgraded shares of Veeva Systems from a “neutral” rating to an “overweight” rating and boosted their price objective for the stock from $290.00 to $330.00 in a research note on Monday, September 8th. Citigroup cut their target price on shares of Veeva Systems from $349.00 to $319.00 and set a “buy” rating for the company in a research note on Monday, November 24th. Finally, Canaccord Genuity Group reiterated a “buy” rating on shares of Veeva Systems in a report on Tuesday, November 25th. Eighteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, Veeva Systems presently has a consensus rating of “Moderate Buy” and a consensus price target of $307.42.

Veeva Systems Stock Up 1.8%

Veeva Systems stock opened at $222.11 on Monday. The stock has a market cap of $36.51 billion, a P/E ratio of 43.21, a P/E/G ratio of 1.64 and a beta of 1.05. Veeva Systems Inc. has a twelve month low of $201.54 and a twelve month high of $310.50. The company’s 50-day moving average price is $265.47 and its two-hundred day moving average price is $276.81.

Veeva Systems (NYSE:VEEV) last issued its quarterly earnings data on Thursday, November 20th. The technology company reported $2.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.95 by $0.09. Veeva Systems had a return on equity of 13.68% and a net margin of 27.93%.The company had revenue of $0.81 million during the quarter, compared to analysts’ expectations of $792.37 million. During the same quarter in the previous year, the company posted $1.75 earnings per share. The business’s revenue was up 16.0% on a year-over-year basis. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. Equities analysts anticipate that Veeva Systems Inc. will post 4.35 earnings per share for the current fiscal year.

Veeva Systems Profile

Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.

Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.